Filing Details

Accession Number:
0001179110-12-007230
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-26 17:59:05
Reporting Period:
2012-04-24
Filing Date:
2012-04-26
Accepted Time:
2012-04-26 17:59:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158223 Affymax Inc AFFY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1344153 H Jeffrey Knapp C/O Affymax, Inc.
4001 Miranda Ave.
Palo Alto CA 94304
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-24 1,500 $6.23 25,755 No 4 M Direct
Common Stock Disposition 2012-04-24 2,414 $12.50 23,341 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-04-24 1,500 $0.00 1,500 $6.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,750 2020-07-21 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The option vests on a monthly basis in equal installments during the 48 month period beginning on July 22, 2010.